Global bio-material-market

1,032 views

Published on

The global market for biomaterials is expected to reach $64.7 billion in 2015 from $25.6 billion in 2008 with a CAGR of 15% from 2010 to 2015. In 2010, the orthopedic biomaterial market recorded revenues of $12 billion or 37.5% of the total global biomaterial market.

Published in: Business, Economy & Finance
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,032
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
52
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Global bio-material-market

  1. 1. Global Biomaterial Market (2010 – 2015)Report SummaryThe global market for biomaterials is expected to reach $64.7 billion in 2015 from$25.6 billion in 2008 with a CAGR of 15% from 2010 to 2015. In 2010, theorthopedic biomaterial market recorded revenues of $12 billion or 37.5% of the totalglobal biomaterial market. This is mainly because of the demand generated by the increasing aging populationworldwide, and introduction of sophisticated technologies in the biomaterials market.However, the orthopedic biomaterials market is estimated to grow slowly, at a CAGRof 12.7% (2010 to 2015) because the market is relatively mature compared to otherproduct markets. Cardiovascular biomaterial is the second-highest market, andcontributed 36.1% to the global biomaterial market in 2010.With the increase in the percentage of aging population worldwide, the number ofindividuals suffering from physical disability is also increasing. Baby boomers bornbetween the years 1946 and 1964 are the major consumers of the biomaterialproducts. Also, more than 20% of the global population is expected to be over 60years in 2050 and this segment of the population will be significantly high indeveloping countries. This increase in the aging population will drive the demand forbiomaterial products.Buy Now: Market Research ReportBrowse All: Global Biomaterial MarketThe biomaterial market definitely holds a significant opportunity for innovators, butextensive research is required to develop new and improved products at competitiveprices. Particularly in the developing countries pricing is a major deciding factor forthe biomaterial markets. The other issue involves regulations that have to bestreamlined. This will open more doors for the development of new and improved products, newopportunities in terms of application areas and eventually increase the market sizefor the products. Biomaterial products are expensive, and an improvement inperformance would justify the higher pricing and also boost the market size. Majordevelopments in the biomaterials market will be witnessed with the cooperationbetween the material suppliers and manufacturing companies; thus streamliningmergers and acquisitions would help the overall market.The U.S. government is expected to spend more in the medical care sector; that, inturn, could boost the market for biomaterials provided the economy revives.The effect of the current economic downturn is also felt by the companiesmanufacturing biomaterial products because although these companies arecompensated by the health insurers, patients have delayed their scheduled
  2. 2. procedures. However, the effect of the poor state of the economy influencing thetiming of surgeries is expected to wane gradually. When that happens, companiesinto the biomaterials market will enjoy higher demand, leading to higher revenues.Markets CoveredThis research report categorizes the biomaterials market into the following:Biomaterial market, by products: Orthopedic, cardiovascular, wound care,gastrointestinal, urological, plastic surgery, and othersBiomaterial market, by materials: Metals, polymers, ceramics, and compositesBiomaterial market, by application: General surgery, surgical appliances andsupplies, surgical and medical instruments, dental products, electro medicalequipment, and other applications.The report provides market estimates and forecasts for the global biomaterialmarket. In addition to market sizing and forecasts, the report offers a detailedanalysis of the market trends, opportunities, and the factors influencing the growthof each segment of the biomaterials market. The report also draws a competitivelandscape, analyzing core competencies of major players and strategies adopted toexpand their market presence.StakeholdersThe targeted audience for this report includes:Pharmaceutical and biotech companiesMedical devices manufacturersPharma-research labsDoctors, physicians, and hospitalsMedical/Pharma associationsRetailers and super-retailersTechnology providersResearch and development (R&D) companiesResearch methodologySecondary research is carried out using proprietary databases (both paid and public),company websites, news articles, etc. The primary research involves interviews withspecialists, CEO’s, managers, and directors working with major market players (keyindustry participants) and subject matter experts from research institutes. Data andanalytic output from secondary research such as markets drivers, restraints, growthopportunities, market forecasts, and others have been validated with primaryresearch.Market size of the segments was calculated using the bottom-up approach andfigures thus derived were added to yield the biomaterial market revenues, while eachyear’s forecast is based on the analysis of industry trends.The primary research involves interviews with specialists, CEO’s, managers, anddirectors from major market players (key industry participants) and subject matterexperts from research institutes. Data & analytic output from secondary research
  3. 3. such as markets drivers, restraints, growth opportunities, market forecasts, andothers were validated with the primary research.Hence, market size of the segments was calculated using bottom-up approach andfigures thus derived were added to yield the biomaterial market revenues; whileeach year’s forecast is based on industry trend analysisTABLE OF CONTENTSEXECUTIVE SUMMARYMARKET OVERVIEW1 INTRODUCTION1.1 KEY TAKE-AWAYS1.2 REPORT DESCRIPTION1.3 MARKETS COVERED1.4 STAKEHOLDERS1.5 RESEARCH METHODOLOGY2 SUMMARY3 MARKET OVERVIEW3.1 INTRODUCTION3.2 DEFINING THE GLOBAL BIOMATERIAL MARKET3.3 DRIVING FACTOR ANALYSIS OF GLOBAL BIOMATERIAL MARKET3.3.1 SUPPLY SIDE DRIVERS3.3.2 DEMAND SIDE DRIVERS3.3.3 RESTRAINTS3.3.4 OPPORTUNITIES3.3.5 KEY COMPETITIVE POINTS3.4 DRIVERS3.4.1 NEW & IMPROVED TECHNOLOGIES3.4.2 DEVELOPMENTS IN BIOCOMPATIBILITY SCIENCE3.4.3 LARGE APPLICATION AREA3.4.4 INTRODUCTION OF BIO-ABSORBABLE BIOMATERIALS3.4.5 RISING AWARENESS3.4.6 MEDICAL APPLICATIONS OF SYNTHETIC BIOMATERIALS3.4.7 BIOMATERIALS HELP TREAT AGE-RELATED PROBLEMS3.4.8 MEDICAL INSURANCE COVERAGE3.4.9 RECENT DEVELOPMENTS IN BIOMATERIAL RESEARCH3.4.10 INCREASING FOCUS ON PERSONAL HEALTHCARE3.5 INHIBITORS3.5.1 LACK OF TISSUE AVAILABILITY3.5.2 LACK OF PROPER REIMBURSEMENT FACILITIES3.6 OPPORTUNITIES3.6.1 MARKET PARTICIPATION BY SMALLER COMPANIES3.6.2 GROWING NEED FOR INTEGRATED & COMBINED MATERIALS
  4. 4. 3.6.3 INTELLIGENT MATERIALS WITH DYNAMIC MOLECULAR FUNCTIONS3.6.4 EMERGING PREFERENCE FOR MINIMALLY INVASIVE SURGERY4 BIOMATERIAL MARKET – BY PRODUCTS4.1 INTRODUCTION4.2 ORTHOPEDIC BIOMATERIAL4.2.1 DRIVERS4.2.1.1 Product penetration4.2.1.2 Increasing use of orthopedic biomaterials in spine surgery4.2.1.3 Easy surgical procedures4.2.2 INHIBITORS4.2.2.1 Economic constraints4.2.2.2 Increasing competition reduces profit margin4.2.3 OPPORTUNITIES4.2.3.1 Spinal treatment expected to be on the rise4.2.4 TOP PLAYER ANALYSIS OF ORTHOPEDIC BIOMATERIAL MARKET4.2.5 ORTHOPEDIC RECONSTRUCTIVE BIOMATERIAL4.2.5.1 Drivers4.2.5.1.1 Wide range of products available for specific applications4.2.5.1.2 Development of new materials with improved properties4.2.5.2 Inhibitors & opportunities4.2.5.3 Top players analysis in orthopedic reconstructive market4.2.5.4 Artificial knee4.2.5.4.1 Constraint implants4.2.5.4.2 Non-constraint implants4.2.5.4.3 Semi-constraint implants4.2.5.5 Artificial hip4.2.5.5.1 Cemented prostheses biomaterial market4.2.5.5.2 Uncemented prostheses biomaterial market4.2.6 ORTHOBIOLOGICS BIOMATERIAL4.2.6.1 Top player analysis of orthobiologics biomaterial market4.2.6.2 Machined bone allografts4.2.6.3 Demineralized bone matrix (DBM)4.2.6.4 Bone morphogenic protein (BMP)4.2.6.5 Synthetic bone substitute4.2.6.6 Non-proprietary allografts4.2.6.7 Platelet concentrates4.2.7 BONE CEMENT4.2.7.1 Drivers4.2.7.1.1 Bone cements ease lesions & can be used with antibiotics4.2.7.2 Inhibitors & opportunities4.2.7.3 Top player analysis of bone cement orthopedic biomaterial market4.2.8 TRAUMA BIOMATERIAL4.2.8.1 Drivers4.2.8.1.1 Sports injuries & other accidents4.2.8.1.2 Plate & screw systems drive overall market growth4.2.8.2 Top players analysis of trauma orthopedic biomaterial market4.2.9 SPINAL BIOMATERIAL4.2.9.1 Drivers
  5. 5. 4.2.9.1.1 Spinal treatment for younger patients on the rise4.2.9.1.2 Motion – preserving devices drive growth4.2.9.2 Inhibitors & Opportunities4.2.9.2.1 Reimbursement challenges restrain growth4.2.9.2.2 Technology & product development provide scope for improvement4.2.9.3 Top player analysis of spine orthopedic biomaterial market4.2.9.4 Cervical biomaterials4.2.9.5 Lumbar biomaterials4.2.10 SPORTS MEDICINE4.2.10.1 Drivers4.2.10.2 Top player analysis of sports medicine orthopedic biomaterial market4.2.11 DENTAL ORTHOPEDICS4.2.11.1 Drivers4.2.11.2 Inhibitors & Opportunities4.2.11.3 Top player analysis of dental orthopedic biomaterial market4.2.11.4 Dental bone grafts and substitutes4.2.11.4.1 Dental allograft4.2.11.4.2 Dental synthetic4.2.11.4.3 Dental xenograft4.2.11.5 Dental membranes4.2.11.6 Tissue regeneration4.3 CARDIOVASCULAR BIOMATERIAL4.3.1 DRIVERS4.3.1.1 Biomaterials enhance cardiovascular treatment4.3.1.2 Rising number of obesity cases4.3.1.3 Increase in thrombosis and heart failure treatments4.3.1.4 Vascular surgery market is growing with the use of biomaterials4.3.2 INHIBITORS & OPPORTUNITIES4.3.3 TOP PLAYER ANALYSIS OF CARDIOVASCULAR BIOMATERIALS MARKET4.3.4 CARDIAC STENTS4.3.4.1 Top player analysis of cardiac stents biomaterial market4.3.5 PERIPHERAL VASCULAR GRAFTS4.3.6 VASCULAR ACCESS DEVICES4.3.6.1 Drivers & Inhibitors4.3.6.2 Top player analysis of vascular access devices biomaterial market4.3.7 CARDIAC PACEMAKER4.3.7.1 Top player analysis of cardiac pacemaker cardiovascular biomaterial market4.3.8 ARTIFICIAL HEART VALVE4.3.8.1 Top player analysis of artificial heart valve cardiovascular biomaterial market4.3.9 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS4.3.9.1 Top player analysis of implantable cardioverter defibrillator cardiovascularbiomaterial market4.4 WOUND CARE BIOMATERIAL4.4.1 DRIVERS4.4.1.1 Multiple advantages over conventional wound care products4.4.1.2 Supports healing process of the skin4.4.1.3 Gel-based products accelerate wound healing4.4.1.4 Prevention of bacterial colonization on sutures4.4.1.5 Reduction in the cost of hospitalization4.4.1.6 Eliminates frequent change of dressings
  6. 6. 4.4.1.7 Increase in diabetes foot ulcer4.4.2 INHIBITORS4.4.2.1 Slow rate of product development4.4.3 OPPORTUNITIES4.4.3.1 Increase in penetration of negative pressure wound4.4.3.2 Introduction of more efficient and cost effective therapies4.4.3.3 Use of natural polymer biomaterials for stability in treatment4.4.4 TOP PLAYER ANALYSIS OF WOUND CARE BIOMATERIAL MARKET4.4.5 SURGICAL HEMOSTATS4.4.5.1 Drivers4.4.5.1.1 Surgical hemostats control bleeding4.4.5.1.2 Reduces need for frequent blood transfusions4.4.5.2 Top player analysis of surgical hemostats market4.4.5.3 Thrombin-based hemostats4.4.5.4 Oxidized regenerated cellulose-based hemostats4.4.5.5 Collagen-based hemostats4.4.5.6 Autologous-based hemostats4.4.5.7 Polysaccharide based hemostats4.4.5.8 Gelatin-based hemostats4.4.5.9 Combination hemostats4.4.6 SKIN SUBSTITUTE4.4.7 INTERNAL TISSUE SEALANT4.4.7.1 Drivers4.4.7.1.1 Technological advances4.4.7.1.2 Wide range of applications & features4.4.7.1.3 Faster healing4.4.7.2 Top player analysis of internal tissue sealant wound care biomaterial market4.4.7.3 Fibrin-based sealants4.4.7.4 Synthetic-based sealant4.4.8 ADHESION BARRIERS4.4.8.1 Drivers4.4.8.2 Inhibitors & Opportunities4.4.8.3 Top player analysis of adhesion prevention wound care biomaterial market4.4.8.4 Films4.4.8.5 Gels4.5 PLASTIC SURGERY BIOMATERIAL4.5.1 DRIVERS4.5.1.1 Baby boomers to boost market growth4.5.1.2 More surgeons are moving towards plastic surgery from reconstructiveprocedures4.5.1.3 Cultural factors boost market growth4.5.2 INHIBITORS & OPPORTUNITIES4.5.2.1 Difficulties in treating craniofacial trauma4.5.2.2 Male population untapped for facial surgeries4.5.3 TOP PLAYER ANALYSIS OF PLASTIC SURGERY BIOMATERIAL MARKET4.5.4 FACIAL IMPLANTS4.5.4.1 Drivers4.5.4.1.1 Iraq war increased demand for facial implants4.5.4.1.2 Faster recovery4.5.4.2 Inhibitors & Opportunities
  7. 7. 4.5.4.3 Top player analysis of facial implants biomaterial market4.5.5 INJECTABLE FILLERS4.5.5.1 Drivers4.5.5.1.1 Increase in awareness of skin care4.5.5.1.2 Permanent results can be achieved using fillers4.5.5.2 Inhibitors & Opportunities4.5.5.2.1 Allergy4.5.5.3 Top player analysis of injectable fillers biomaterial market4.5.6 BREAST IMPLANTS4.5.6.1 Drivers4.5.6.1.1 Availability of more refined procedures4.5.6.2 Inhibitors & Opportunities4.5.6.3 Top player analysis of breast implants biomaterial market4.5.6.4 Silicone gel implants4.5.6.5 Saline-filled implants4.6 UROLOGICAL BIOMATERIAL4.6.1 DRIVERS4.6.1.1 Availability of biodegradable materials for treatment4.6.1.2 Development of scaffolds for treatment of several disorders4.6.2 INHIBITORS & OPPORTUNITIES4.6.3 TOP PLAYER ANALYSIS OF UROLOGICAL BIOMATERIAL MARKET4.6.4 STENTS4.6.4.1 Drivers4.6.4.1.1 Stents are used in short duration treatment4.6.4.1.2 Growing population4.6.4.2 Inhibitors & Opportunities4.6.5 CATHETERS4.6.5.1 Drivers & Inhibitors4.6.5.1.1 Developments in catheter design increased applicability4.6.5.1.2 Prolonged use of catheters may lead to cancer4.6.5.2 Opportunities4.6.5.2.1 Use of biomaterials in catheters eliminates certain disadvantages4.6.5.2.2 Biocompatibility of chemicals can be improved in catheters4.6.5.3 Dialysis catheter4.6.5.3.1 Top player analysis of dialysis catheter market4.6.5.3.2 Hemodialysis catheter4.6.5.3.3 Peritonial catheter4.6.5.4 Urinary catheter4.7 GASTROINTESTINAL BIOMATERIAL4.7.1 DRIVERS4.7.1.1 Increasing incidence of gastrointestinal diseases4.7.1.2 FDA approval for OTC gastrointestinal drugs4.7.2 INHIBITORS & OPPORTUNITIES4.7.3 TOP PLAYER ANALYSIS OF GASTROINTESTINAL BIOMATERIAL MARKET5 BIOMATERIAL MARKET – BY TYPES5.1 INTRODUCTION5.2 METALS5.2.1 DRIVERS
  8. 8. 5.2.1.1 Balancing act of metallic biomaterials5.2.1.2 Improved properties of metallic biomaterials5.2.2 INHIBITORS5.2.2.1 Corrosion may occur in the implant5.2.3 OPPORTUNITIES5.2.3.1 Improvement in corrosion resistance5.2.3.2 Introduction of new alloys5.2.4 TOP PLAYER ANALYSIS OF METALLIC BIOMATERIAL MARKET5.2.5 PURE FORM METALS5.2.5.1 Titanium5.2.5.2 Platinum5.2.5.3 Silver5.2.5.4 Gold5.2.6 ALLOYS5.2.6.1 Drivers5.2.6.1.1 Easy availability of ore for biomaterials manufacture5.2.6.1.2 Can be sterilized easily5.2.6.2 Inhibitors & Opportunities5.2.6.3 Top player analysis of alloy biomaterial market5.2.6.4 High carbon cobalt chromium alloy5.3 CERAMICS5.3.1 TOP PLAYER ANALYSIS OF CERAMICS BIOMATERIAL MARKET5.3.2 BIOINERT CERAMICS5.3.2.1 Drivers5.3.2.1.1 Compatibility with high-strength applications5.3.2.1.2 High chemical stability5.3.2.2 Inhibitors & Opportunities5.3.2.3 Alumina5.3.2.4 Zirconia ceramic5.3.2.5 Other bioinert ceramics market5.3.3 BIOACTIVE CERAMICS5.3.3.1 Drivers5.3.3.1.1 Ceramics aid bone formation5.3.3.2 Inhibitors & Opportunities5.3.3.3 Bioglass5.3.3.4 Other bioactive ceramics market5.3.4 BIODEGRADABLE CERAMICS5.3.4.1 Hydroxyapetite5.3.4.2 Others biodegradable biomaterial market5.4 POLYMERS5.4.1 DRIVERS5.4.1.1 Naturally biodegradable5.4.1.2 Compatibility in imaging5.4.2 INHIBITORS & OPPORTUNITIES5.4.3 TOP PLAYER ANALYSIS OF POLYMER BIOMATERIAL MARKET5.4.4 NATURAL POLYMERS5.4.4.1 Drivers5.4.4.1.1 Safe to use5.4.4.1.2 Work at a molecular level5.4.4.2 Inhibitors & Opportunities
  9. 9. 5.4.4.3 Collagen-based biomaterials5.4.4.3.1 Drivers5.4.4.4 Chitosan5.4.4.5 Alginate5.4.4.6 Others natural polymers5.4.5 SYNTHETIC POLYMER BIOMATERIAL5.4.5.1 Hyaluronic acid (HA)5.4.5.2 PLA/PGA (poly lactic acid/Poly lactic-co glycolic acid)5.4.5.3 PTFE (polytetrafluoroethylene)5.4.5.4 Other synthetic polymers6 BIOMATERIAL MARKET – BY APPLICATIONS6.1 INTRODUCTION6.2 SURGICAL APPLIANCES & SUPPLIES6.2.1 DRIVERS6.2.1.1 Advanced materials for surgical appliances6.2.1.2 Advances in orthopedic & prosthetic applications6.2.1.3 Increased healthcare spending in developed countries6.2.1.4 No side effects6.2.1.5 Biomaterials accelerate natural phenomena6.2.2 MARKET INHIBITORS6.2.2.1 Lack of capital investment in R&D6.2.2.2 Slow approval process6.2.3 OPPORTUNITIES6.2.3.1 Increase in export opportunities6.2.3.2 Future development of artificial organs6.2.3.3 Treatment for sleep disorders6.3 SURGICAL & MEDICAL INSTRUMENTS6.3.1 DRIVERS6.3.1.1 Innovations in surgical instruments6.3.1.2 Availability of cheap surgical instruments6.3.2 INHIBITORS & OPPORTUNITIES6.4 DRUG DELIVERY6.4.1 DRIVERS6.4.1.1 Enabling properties of biomaterials6.4.1.2 Most biomaterials are bio-absorbable6.4.1.3 Development of quick & effective methods6.4.2 INHIBITORS & OPPORTUNITIES6.4.2.1 Adverse side effects from certain biomaterials inhibit growth6.4.2.2 Nano biomaterials for controlled drug delivery6.5 GENERAL SURGERY6.5.1 DRIVERS6.5.1.1 Synthetic biomaterials make suturing easier6.5.1.2 Biomaterials meet the stringent requirements of surgeons6.5.1.3 Biomaterials are used as adhesion prevention materials6.5.2 INHIBITORS & OPPORTUNITIES6.6 ELECTRO-MEDICAL EQUIPMENT6.6.1 DRIVERS6.6.1.1 Significant increase in patient-base
  10. 10. 6.6.1.2 Demand for efficient procedures and economies of scale6.6.2 INHIBITORS & OPPORTUNITIES6.7 DENTAL PRODUCTS6.7.1 DRIVERS6.7.1.1 Biomaterials have wide range of dental applications6.7.1.2 Risk of dental disease is set to increase6.7.1.3 Improvement in polymers for dental applications6.7.2 INHIBITORS & OPPORTUNITIES6.8 OTHER APPLICATIONS7 GEOGRAPHIC ANALYSIS7.1 INTRODUCTION7.2 U.S.7.3 EUROPE7.4 ASIA8 COMPANY PROFILES8.1 3DM INC.8.1.1 OVERVIEW8.1.2 PRODUCTS & SERVICES8.1.3 STRATEGY8.1.4 DEVELOPMENTS8.2 ADVANSOURCE BIOMATERIALS CORP8.2.1 OVERVIEW8.2.2 FINANCIALS8.2.3 PRODUCTS & SERVICES8.2.4 STRATEGY8.2.5 DEVELOPMENTS8.3 ALLERGAN INC.8.3.1 OVERVIEW8.3.2 FINANCIALS8.3.3 PRODUCTS & SERVICES8.3.4 STRATEGY8.3.5 DEVELOPMENTS8.4 ALLOSOURCE INC.8.4.1 OVERVIEW8.4.2 PRODUCTS & SERVICES8.4.3 STRATEGY8.4.4 DEVELOPMENTS8.5 ALPHATEC SPINE INC.8.5.1 OVERVIEW8.5.2 FINANCIALS8.5.3 PRODUCTS & SERVICES8.5.4 STRATEGY8.5.5 DEVELOPMENTS8.6 AMEDICA CORPORATION8.6.1 OVERVIEW8.6.2 PRODUCTS & SERVICES
  11. 11. 8.6.3 STRATEGY8.6.4 DEVELOPMENTS8.7 ANGIOTECH PHARMACEUTICALS INC.8.7.1 OVERVIEW8.7.2 FINANCIALS8.7.3 PRODUCTS & SERVICES8.7.4 STRATEGY8.7.5 DEVELOPMENTS8.8 ARTIMPLANT AB8.8.1 OVERVIEW8.8.2 PRODUCTS & SERVICES8.8.3 STRATEGY8.8.4 DEVELOPMENTS8.9 BAXTER INTERNATIONAL INC.8.9.1 OVERVIEW8.9.2 FINANCIALS8.9.3 PRODUCTS & SERVICES8.9.4 STRATEGY8.9.5 DEVELOPMENTS8.10 BIO SYNTECH CANADA INC.8.10.1 OVERVIEW8.10.2 PRODUCTS & SERVICES8.11 BIOCOMPOSITES LTD.8.11.1 OVERVIEW8.11.2 PRODUCTS & SERVICES8.11.3 STRATEGY8.11.4 DEVELOPMENTS8.12 BIOMET INC.8.12.1 OVERVIEW8.12.2 FINANCIALS8.12.3 PRODUCTS & SERVICES8.12.4 STRATEGY8.12.5 DEVELOPMENTS8.13 BOSTON SCIENTIFIC CORPORATION8.13.1 OVERVIEW8.13.2 FINANCIALS8.13.3 PRODUCTS & SERVICES8.13.4 STRATEGY8.13.5 DEVELOPMENTS8.14 COLLAGEN MATRIX INC.8.14.1 OVERVIEW8.14.2 PRODUCTS & SERVICES8.14.3 STRATEGY8.14.4 DEVELOPMENTS8.15 COLLPLANT LTD.8.15.1 OVERVIEW8.15.2 PRODUCTS & SERVICES8.15.3 STRATEGY8.15.4 DEVELOPMENTS8.16 COVALON TECHNOLOGIES LTD.
  12. 12. 8.16.1 OVERVIEW8.16.2 FINANCIALS8.16.3 PRODUCTS & SERVICES8.16.4 STRATEGY8.16.5 DEVELOPMENTS8.17 CRYOLIFE INC.8.17.1 OVERVIEW8.17.2 FINANCIALS8.17.3 PRODUCTS & SERVICES8.17.4 STRATEGY8.17.5 DEVELOPMENTS8.18 DEPUY ORTHOPEDICS INC.8.18.1 OVERVIEW8.18.2 FINANCIALS8.18.3 PRODUCTS & SERVICES8.18.4 STRATEGY8.18.5 DEVELOPMENTS8.19 ETEX CORPORATION8.19.1 OVERVIEW8.19.2 PRODUCTS & SERVICES8.20 INTEGRA LIFE SCIENCES HOLDINGS CORP8.20.1 OVERVIEW8.20.2 FINANCIALS8.20.3 PRODUCTS & SERVICES8.20.4 STRATEGY8.20.5 DEVELOPMENTS8.21 INVIBIO LIMITED8.21.1 OVERVIEW8.21.2 PRODUCTS & SERVICES8.21.3 STRATEGY8.21.4 DEVELOPMENTS8.22 MEDTRONIC INC.8.22.1 OVERVIEW8.22.2 FINANCIALS8.22.3 PRODUCTS & SERVICES8.22.4 STRATEGY8.22.5 DEVELOPMENTS8.23 ORTHOVITA INC.8.23.1 OVERVIEW8.23.2 FINANCIALS8.23.3 PRODUCTS & SERVICES8.23.4 STRATEGY8.23.5 DEVELOPMENTS8.24 RTI BIOLOGICS INC.8.24.1 OVERVIEW8.24.2 FINANCIALS8.24.3 PRODUCTS & SERVICES8.24.4 STRATEGY8.24.5 DEVELOPMENTS8.25 SMITH & NEPHEW PLC
  13. 13. 8.25.1 OVERVIEW8.25.2 FINANCIALS8.25.3 PRODUCTS & SERVICES8.25.4 STRATEGY8.25.5 DEVELOPMENTS8.26 ST. JUDE MEDICAL INC.8.26.1 OVERVIEW8.26.2 FINANCIALS8.26.3 PRODUCTS & SERVICES8.26.4 STRATEGY8.26.5 DEVELOPMENTS8.27 STRYKER CORPORATION8.27.1 OVERVIEW8.27.2 FINANCIALS8.27.3 PRODUCTS & SERVICES8.27.4 STRATEGY8.27.5 DEVELOPMENTS8.28 SYNTHES INC.8.28.1 OVERVIEW8.28.2 FINANCIALS8.28.3 PRODUCTS & SERVICES8.28.4 STRATEGY8.28.5 DEVELOPMENTS8.29 WRIGHT MEDICAL GROUP, INC.8.29.1 OVERVIEW8.29.2 FINANCIALS8.29.3 PRODUCTS & SERVICES8.29.4 STRATEGY8.29.5 DEVELOPMENTS8.30 ZIMMER HOLDING, INC.8.30.1 OVERVIEW8.30.2 FINANCIALS8.30.3 PRODUCTS & SERVICES8.30.4 STRATEGY8.30.5 DEVELOPMENTSAPPENDIXPRODUCTSU.S. PATENTSEUROPE PATENTSJAPAN PATENTSBIOMATERIALSU.S. PATENTSEUROPE PATENTSJAPAN PATENTS
  14. 14. LIST OF TABLES1 GLOBAL BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)2 GLOBAL ORTHOPEDIC BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 –2015 ($MILLION)3 ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015($MILLION)4 GLOBAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 –2015 ($MILLION)5 MAJOR PLAYERS & DEVELOPMENTS6 GLOBAL RECONSTRUCTIVE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYPRODUCTS 2008 – 2015 ($MILLION)7 RECONSTRUCTIVE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)8 GLOBAL RECONSTRUCTIVE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYDEVICES 2008 – 2015 ($MILLION)9 MAJOR PLAYERS & DEVELOPMENTS10 GLOBAL ARTIFICIAL KNEE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYPRODUCTS 2008 – 2015 ($MILLION)11 ARTIFICIAL KNEE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)12 CONSTRAINT IMPLANTS ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)13 NON-CONSTRAINT IMPLANT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)14 SEMI-CONSTRAINT IMPLANTS ORTHOPEDICS BIOMATERIAL MARKET REVENUE,BY GEOGRAPHY 2008 – 2015 ($MILLION)15 GLOBAL ARTIFICIAL HIP ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYPRODUCTS 2008 – 2015 ($MILLION)16 ARTIFICIAL HIP ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY2008 – 2015 ($MILLION)17 CEMENTED PROSTHESES ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)18 UNCEMENTED PROSTHESES ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)19 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS2008 – 2015 ($MILLION)20 ORTHOBIOLOGICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 –2015 ($MILLION)21 GLOBAL ORTHOBIOLOGICS BIOMATERIAL MARKET REVENUE, BY DEVICES 2008– 2015 ($MILLION)22 MAJOR PLAYERS & DEVELOPMENTS23 MACHINE BONE ALLOGRAFT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)24 DBM ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 –2015 ($MILLION)25 BMP ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 –2015 ($MILLION)
  15. 15. 26 SYNTHETIC BONE SUBSTITUTE ORTHOPEDICS BIOMATERIAL MARKET REVENUE,BY GEOGRAPHY 2008 – 2015 ($MILLION)27 NON-PROPRIETARY ALLOGRAFTS ORTHOPEDICS BIOMATERIAL MARKETREVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)28 PLATELET CONCENTRATES ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)29 BONE CEMENT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY2008 – 2015 ($MILLION)30 MAJOR PLAYERS & DEVELOPMENTS31 GLOBAL TRAUMA ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS2008 – 2015 ($MILLION)32 TRAUMA ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008– 2015 ($MILLION)33 GLOBAL TRAUMA ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY DEVICES2008 – 2015 ($MILLION)34 MAJOR PLAYERS & PRODUCT DEVELOPMENT35 GLOBAL SPINAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS2008 – 2015 ($MILLION)36 SPINAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 –2015 ($MILLION)37 GLOBAL SPINAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY DEVICES2008 – 2015 ($MILLION)38 MAJOR PLAYERS & DEVELOPMENTS39 GLOBAL CERVICAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYPRODUCTS 2008 – 2015 ($MILLION)40 CERVICAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY2008 – 2015 ($MILLION)41 GLOBAL LUMBAR ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS2008 – 2015 ($MILLION)42 LUMBAR SPINAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)43 SPORTS MEDICINE ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)44 MAJOR PLAYERS & DEVELOPMENTS45 GLOBAL DENTAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY PRODUCTS2008 – 2015 ($MILLION)46 DENTAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008– 2015 ($MILLION)47 GLOBAL DENTAL ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY DEVICES2008 – 2015 ($MILLION)48 MAJOR PLAYERS & DEVELOPMENTS49 GLOBAL DENTAL BONE GRAFTS & SUBSTITUTES ORTHOPEDICS BIOMATERIALMARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)50 DENTAL BONE GRAFTS & SUBSTITUTES ORTHOPEDIC BIOMATERIAL MARKETREVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)51 DENTAL ALLOGRAFT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)52 DENTAL SYNTHETIC ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)53 DENTAL XENOGRAFT ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BY
  16. 16. GEOGRAPHY 2008 – 2015 ($MILLION)54 DENTAL MEMBRANES ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)55 TISSUE REGENERATION ORTHOPEDICS BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)56 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY PRODUCTS2008 – 2015 ($MILLION)57 CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 –2015 ($MILLION)58 GLOBAL CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BY DEVICES 2008– 2015 ($MILLION)59 MAJOR PLAYERS & PRODUCT DEVELOPMENTS60 GLOBAL CARDIAC STENTS CARDIOVASCULAR BIOMATERIAL MARKET REVENUE,BY PRODUCTS 2008 – 2015 ($MILLION)61 CARDIAC STENTS CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)62 MAJOR PLAYERS & PRODUCT DEVELOPMENTS63 PERIPHERAL VASCULAR GRAFTS CARDIOVASCULAR BIOMATERIAL MARKETREVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)64 GLOBAL VASCULAR ACCESS DEVICE CARDIOVASCULAR BIOMATERIAL MARKETREVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)65 VASCULAR ACCESS DEVICE CARDIOVASCULAR BIOMATERIAL MARKET REVENUE,BY GEOGRAPHY 2008 – 2015 ($MILLION)66 MAJOR PLAYERS & DEVELOPMENTS67 CARDIAC PACEMAKER CARDIOVASCULAR BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)68 MAJOR PLAYERS & DEVELOPMENTS69 GLOBAL ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIAL MARKETREVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)70 ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIAL MARKET REVENUE,BY GEOGRAPHY 2008 – 2015 ($MILLION)71 MAJOR PLAYERS & DEVELOPMENTS72 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS CARDIOVASCULARBIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)73 MAJOR PLAYERS & DEVELOPMENTS74 GLOBAL WOUND CARE BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 –2015 ($MILLION)75 WOUND CARE BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015($MILLION)76 GLOBAL WOUND CARE BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 –2015 ($MILLION)77 MAJOR PLAYERS & DEVELOPMENTS78 GLOBAL SURGICAL HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE,BY PRODUCTS 2008 – 2015 ($MILLION)79 SURGICAL HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)80 MAJOR PLAYERS & DEVELOPMENTS81 THROMBIN-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE,BY GEOGRAPHY 2008 – 2015 ($MILLION)82 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS WOUND CARE
  17. 17. BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)83 COLLAGEN-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE,BY GEOGRAPHY 2008 – 2015 ($MILLION)84 AUTOLOGOUS-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKETREVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)85 POLYSACCHARIDE-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKETREVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)86 GELATIN-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)87 COMBINATION-BASED HEMOSTATS WOUND CARE BIOMATERIAL MARKETREVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)88 SKIN SUBSTITUTE WOUND CARE BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)89 GLOBAL INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIAL MARKETREVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)90 INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)91 MAJOR PLAYERS & DEVELOPMENTS92 FIBRIN-BASED SEALANT WOUND CARE BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)93 SYNTHETIC-BASED SEALANT WOUND CARE BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)94 GLOBAL ADHESION BARRIERS WOUND CARE BIOMATERIAL MARKET REVENUE,BY PRODUCTS 2008 – 2015 ($MILLION)95 ADHESION BARRIERS WOUND CARE BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)96 MAJOR PLAYERS & DEVELOPMENTS97 FILMS ADHESION BARRIERS WOUND CARE BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)98 GELS ADHESION BARRIERS WOUND CARE BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)99 GLOBAL PLASTIC SURGERY BIOMATERIAL MARKET, BY PRODUCTS 2008 – 2015($MILLION)100 PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 –2015 ($MILLION)101 GLOBAL PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BY DEVICES2008 – 2015 ($MILLION)102 MAJOR PLAYERS & DEVELOPMENT103 FACIAL IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)104 MAJOR PLAYERS & DEVELOPMENTS105 GLOBAL INJECTABLE FILLERS PLASTIC SURGERY BIOMATERIAL MARKETREVENUE, BY GEOGRAPHY 2008 – 2015 ($MILLION)106 MAJOR PLAYERS & DEVELOPMENTS107 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKETREVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)108 BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)109 GLOBAL BREAST IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKETREVENUE, BY DEVICES 2008 – 2015 ($MILLION)
  18. 18. 110 MAJOR PLAYERS & DEVELOPMENTS111 SILICONE GEL IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE,BY GEOGRAPHY 2008 – 2015 ($MILLION)112 SALINE-FILLED IMPLANTS PLASTIC SURGERY BIOMATERIAL MARKET REVENUE,BY GEOGRAPHY 2008 – 2015 ($MILLION)113 GLOBAL UROLOGICAL BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 –2015 ($MILLION)114 UROLOGICAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 – 2015($MILLION)115 GLOBAL UROLOGICAL BIOMATERIAL MARKET REVENUE, BY DEVICES 2008 –2015 ($MILLION)116 MAJOR PLAYERS & DEVELOPMENTS117 UROLOGICAL STENTS MARKET REVENUE, BY GEOGRAPHY 2008 – 2015($MILLION)118 GLOBAL UROLOGICAL CATHETERS MARKET REVENUE, BY PRODUCTS 2008 –2015 ($MILLION)119 UROLOGICAL CATHETERS MARKET REVENUE, BY GEOGRAPHY 2008 – 2015($MILLION)120 GLOBAL DIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE,BY PRODUCTS 2008 – 2015 ($MILLION)121 DIALYSIS CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)122 MAJOR PLAYERS & DEVELOPMENTS123 EMODIALYSIS UROLOGICAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY2008 – 2015 ($MILLION)124 PERITONEAL CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)125 GLOBAL URINARY CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE, BYPRODUCTS 2008 – 2015 ($MILLION)126 URINARY CATHETER UROLOGICAL BIOMATERIAL MARKET REVENUE, BYGEOGRAPHY 2008 – 2015 ($MILLION)127 GASTROINTESTINAL BIOMATERIAL MARKET REVENUE, BY GEOGRAPHY 2008 –2015 ($MILLION)128 MAJOR PLAYERS & DEVELOPMENTS129 GLOBAL BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015 ($MILLION)130 GLOBAL METALS BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015($MILLION)131 MAJOR PLAYERS & DEVELOPMENTS132 GLOBAL PURE FORM METALS BIOMATERIAL MARKET REVENUE, BY TYPES 2008– 2015 ($MILLION)133 GLOBAL ALLOY BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015($MILLION)134 MAJOR PLAYERS & DEVELOPMENTS135 GLOBAL CERAMICS BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015($MILLION)136 MAJOR PLAYERS & DEVELOPMENT137 TECHNOLOGICAL ADVANCEMENTS IN CERAMICS138 GLOBAL BIOINERT CERAMICS MARKET REVENUE, BY TYPES 2008 – 2015($MILLION)139 GLOBAL BIOACTIVE CERAMICS MARKET REVENUE, BY TYPES 2008 – 2015
  19. 19. ($MILLION)140 GLOBAL BIODEGRADABLE CERAMICS MARKET REVENUE, BY TYPES 2008 –2015 ($MILLION)141 GLOBAL POLYMER BIOMATERIAL MARKET REVENUE, BY TYPES 2008 – 2015($MILLION)142 MAJOR PLAYERS & DEVELOPMENTS143 GLOBAL NATURAL POLYMERS BIOMATERIAL MARKET REVENUE, BY TYPES 2008– 2015 ($MILLION)144 GLOBAL SYNTHETIC POLYMER BIOMATERIAL MARKET REVENUE, BY TYPES 2008– 2015 ($MILLION)145 GLOBAL BIOMATERIAL APPLICATIONS MARKET REVENUE, BY TYPES 2008 –2015 ($MILLION)146 BIOMATERIAL PRODUCTS MARKET REVENUE, BY GEOGRAPHY 2008 – 2015($MILLION)147 U.S. BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)148 EUROPE BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015($MILLION)149 ASIA BIOMATERIAL MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($MILLION)150 ADVANSOURCE BIOMATERIAL REVENUES AND R&D EXPENSES ($MILLION)151 ADVANSOURCE BIOMATERIAL REVENUES, BY SEGMENTS ($MILLION)152 ALLERGAN REVENUES AND R&D EXPENSES ($MILLION)153 ALLERGAN REVENUES, BY SEGMENT ($MILLION)154 ALLERGAN MEDICAL DEVICES REVENUES, BY SEGMENTS ($MILLION)155 ALLERGAN REVENUES, BY GEOGRAPHY ($MILLION)156 ALPHATEC SPINE REVENUES AND R&D EXPENSES ($MILLION)157 APLHATEC SPINE REVENUES, BY GEOGRAPHY ($MILLION)158 ANGIOTECH REVENUES AND R&D EXPENSES ($MILLION)159 ANGIOTECH REVENUES, BY GEOGRAPHY ($MILLION)160 BAXTER SALES, BY SEGMENTS ($MILLION)161 BAXTER SALES, BY GEOGRAPHY ($MILLION)162 BIOMET REVENUES AND R&D EXPENSES ($MILLION)163 BIOMET REVENUES, BY SEGMENTS ($MILLION)164 BOSTON SCIENTIFIC REVENUES AND R&D EXPENSES ($MILLION)165 BOSTON SCIENTIFIC REVENUES, BY GEOGRAPHY ($MILLION)166 COVALON REVENUES AND R&D EXPENSES ($’000)167 COVALON REVENUES, BY SEGMENTS ($’000)168 CRYOLIFE REVENUES AND R&D EXPENSES ($’000)169 CRYOLIFE REVENUES, BY SEGMENTS ($’000)170 DEPUY SALES ($BILLION)171 INTEGRA REVENUES AND R&D EXPENSES ($MILLION)172 INTEGRA REVENUES, BY GEOGRAPHY ($MILLION)173 INTEGRA REVENUES, BY SEGMENTS ($MILLION)174 MEDTRONIC REVENUES AND R&D EXPENSES ($MILLION)175 MEDTRONIC REVENUES, BY SEGMENTS ($MILLION)176 ORTHOVITA REVENUES AND R&D EXPENSES ($’000)177 ORTHOVITA REVENUES, BY GEOGRAPHY ($’000)178 ORTHOVITA REVENUES, BY SEGMENTS ($’000)179 RTI BIOLOGICS REVENUES AND R&D EXPENSES ($’000)180 RTI BIOLOGICS REVENUES, BY SEGMENT (‘000)181 SMITH & NEPHEW REVENUES AND R&D EXPENSES ($MILLION)
  20. 20. 182 SMITH & NEPHEW REVENUES, BY GEOGRAPHY ($MILLION)183 SMITH & NEPHEW REVENUE, BY SEGMENTS ($MILLION)184 ST. JUDE SALES AND R&D EXPENSES ($MILLION)185 ST. JUDE SALES, BY SEGMENTS ($MILLION)186 ST. JUDE SALES, BY GEOGRAPHY ($MILLION)187 STRYKER REVENUES AND R&D EXPENSES ($MILLION)188 STRYKER REVENUES, BY SEGMENTS ($MILLION)189 STRYKER REVENUES, BY GEOGRAPHY ($MILLION)190 SYNTHES REVENUES AND R&D EXPENSES ($MILLION)191 SYNTHES REVENUES, BY GEOGRAPHY ($MILLION)192 WRIGHT MEDICAL REVENUES AND R&D EXPENSES ($MILLION)193 WRIGHT MEDICAL REVENUES, BY SEGMENTS ($MILLION)194 WRIGHT MEDICAL REVENUES, BY GEOGRAPHY ($MILLION)195 ZIMMER REVENUES AND R&D EXPENSES ($MILLION)196 ZIMMER REVENUES, BY GEOGRAPHY ($MILLION)197 ZIMMER REVENUES, BY SEGMENTS ($MILLION)LIST OF FIGURES1 GLOBAL BIOMATERIAL MARKET2 EVOLUTION OF BIOMATERIAL MARKET3 PARENTAL STRUCTURE OF BIOMATERIAL MARKET4 CHARACTERISTICS OF BIOMATERIAL SCIENCE5 BIOMATERIAL MARKET: SEGMENTATION6 RELATIVE POTENTIAL MATRIX FOR BIOMATERIAL PRODUCTS MARKET (2014)7 INCREASING DISABILITY WITH AGE8 INCREASING AGING POPULATION9 GEOGRAPHICAL ANALYSIS OF BIOMATERIAL MARKET (2010)10 FACTORS AFFECTING THE BIOMATERIAL MARKET11 BIOMATERIAL PATENTS, BY GEOGRAPHYRelated Market Research Reports :Global Biomaterial Market (2010 – 2015)Global Animal Feed Additives By Types, Livestock, Geography, Regulations, Trends & Forecasts (2009 – 2016)Global Carbon Nanotubes Market – SWCNTS, MWCNTS, Technology, Applications, Trends & Outlook (2011 – 2016)Private Wealth Management India – Family Offices for Ultra-High Net worth Individual (UHNWI) 2010-2015: (Trends and Needs Behavior Analysis)Global Respiratory Care Devices Market (2010 – 2015)Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC) (2010 – 2015)Global Food Safety Testing Market by Contaminants, Technology, Food Types, Geography: Trends & Forecast (2010 – 2015)
  21. 21. About Us:ReportsnReports is comprising of an online library of 10,000 reports, in-depth marketresearch studies ofover 5000 micro markets, and 25 industry specific websites.Our client list boasts of almost all well-known publishers of such reports across theglobe. We, as a thirdparty reseller of market research reports employ number of marketing tools such aspress releases,email-marketing and effective search engine optimization technique to driverevenues for our clients.We also provide 24/7 online and offline support to our customers.Contact:Ms.Sunita7557 Rambler road,Suite727,Dallas,TX75231Tel: +1-888-989-8004Website: http://www.reportsnreports.comBlog: http://www.salisonline.org/

×